Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE

CompletedOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Ischemic Heart Disease
Interventions
OTHER

cell therapy

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
collaborator

Nantes University Hospital

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

Medical University of Silesia

OTHER

collaborator

Hannover Medical School

OTHER

collaborator

VZW Cardiovascular Research Center Aalst

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

Johann Wolfgang Goethe University Hospital

OTHER

collaborator

University of Ulm

OTHER

collaborator

Military Medical Academy, Belgrade, Serbia

OTHER

collaborator

Novosibirsk Scientific Research Institute for Circulatory Pathology

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Asklepios Kliniken Hamburg GmbH

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

University of Debrecen

OTHER

collaborator

University of Targu Mures, Romania

OTHER

collaborator

University Clinic for Cardiology, Skopje, Republic of Macedonia

UNKNOWN

collaborator

State Health Center, Hungary

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

University of Zurich

OTHER

collaborator

University of Oulu

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Minneapolis Heart Institute

OTHER

collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

Klinik Hirslanden, Zurich

OTHER

collaborator

University Hospital, Toulouse

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

lead

Medical University of Vienna

OTHER

NCT01098591 - Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE | Biotech Hunter | Biotech Hunter